Segui
Francesca Cappelletti
Francesca Cappelletti
Università Vita-Salute San Raffaele, Milan
Email verificata su hsr.it
Titolo
Citata da
Citata da
Anno
Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by …
M Castelli, F Cappelletti, RA Diotti, G Sautto, E Criscuolo, M Dal Peraro, ...
Journal of Immunology Research 2013, 2013
402013
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes
N Clementi, E Criscuolo, F Cappelletti, R Burioni, M Clementi, N Mancini
Drug discovery today 21 (4), 682-691, 2016
192016
Role and potential therapeutic use of antibodies against herpetic infections
N Clementi, F Cappelletti, E Criscuolo, M Castelli, N Mancini, R Burioni, ...
Clinical Microbiology and Infection 23 (6), 381-386, 2017
172017
Virus-induced preferential antibody gene-usage and its importance in humoral autoimmunity
F Cappelletti, N Clementi, N Mancini, M Clementi, R Burioni
Seminars in immunology 27 (2), 138-143, 2015
152015
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy
RA Diotti, N Mancini, N Clementi, G Sautto, GJ Moreno, E Criscuolo, ...
Antiviral Research 108, 94-103, 2014
142014
Entry inhibition of HSV-1 and-2 protects mice from viral lethal challenge
N Clementi, E Criscuolo, F Cappelletti, P Quaranta, M Pistello, RA Diotti, ...
Antiviral research 143, 48-61, 2017
102017
Epitope mapping by epitope excision, hydrogen/deuterium exchange, and peptide-panning techniques combined with in silico analysis
N Clementi, N Mancini, E Criscuolo, F Cappelletti, M Clementi, R Burioni
Monoclonal Antibodies: Methods and Protocols, 427-446, 2014
102014
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice
M Retamal, Y Abed, C Rhéaume, F Cappelletti, N Clementi, N Mancini, ...
Antimicrobial Agents and Chemotherapy 59 (5), 2647-2653, 2015
22015
IN VIVO PROTECTION CONFERRED BY HUMAN MONOCLONAL ANTIBODY DIRECTED AGAINST HSV-1 AND 2
E Criscuolo, F Cappelletti, N Clementi, RA Diotti, M Castelli, N Mancini, ...
ABSTRACT BOOK 3° ITALIAN EXPERIENCE IN BIOMEDICAL RESEARCH: YOUNG MINDS AT WORK, 2015
2015
Human monoclonal antibody endowed with anti-HSV-1 and-2 activity strongly inhibits virus replication
F Cappelletti, E Criscuolo, N Clementi, G Sautto, V Caputo, N Mancini, ...
3rd Italian experience in biomedical research: young minds at work, 65-65, 2015
2015
Broadly neutralizing human monoclonal antibodies: a novel resource against influenza viruses
E Criscuolo, F Cappelletti, N Clementi, N Mancini, G Sautto, R Diotti, ...
Front. Immunol. Conference Abstract: 15th International Congress of …, 2013
2013
Synergistic neutralization of HCV by two broadly neutralizing human monoclonal antibodies
E Criscuolo, F Cappelletti, G Sautto, R Diotti, N Clementi, N Mancini, ...
3rd EUSPM Congress, 2013
2013
Broadly anti-hepatitis C virus (HCV) cross-neutralizing monoclonal antibodies (mAbs) directed against the HCV/E2 glycoprotein and not subjected to Ab-mediated interference
GA Sautto, N Mancini, G Gorini, RA Diotti, N Clementi, E Criscuolo, ...
Front. Immunol. Conference Abstract: 15th International Congress of …, 2013
2013
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome
E Criscuolo, F Cappelletti, GA Sautto, RA Diotti, N Clementi, N Mancini, ...
Clinical Biochemistry 12 (46), 1157-1157, 2013
2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–14